Sahajanand Medical Technologies Limited
Clinical trials sponsored by Sahajanand Medical Technologies Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Thousands enrolled in supraflex stent registry for coronary artery disease Results expected Jun 2027 (estimated)
- New heart valve study aims to improve life for patients with narrowed aortic valve Results expected Jul 2027 (estimated)
-
New heart valve study aims to improve life for patients with narrowed aortic valve
Disease control Recruiting nowThis study is testing a new heart valve called Hydra for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. About 250 participants will get the valve through a tube in an artery, and researchers will check how safe and effective it is for…
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New stent aims to tackle multiple blocked arteries in one go
Disease control Recruiting nowThis study is testing a special stent called Supraflex Cruz in 1000 people who have blockages in more than one heart artery. The stent is coated with a drug (sirolimus) that slowly releases to help keep the artery open, and the coating dissolves over time. Researchers want to see…
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New heart valve study aims to improve treatment for narrowed aortic valve
Disease control Recruiting nowThis study is testing a new heart valve called Hydra in 50 people with severe aortic stenosis, a condition where the heart's main valve narrows. The goal is to see if the valve is safe and works well for up to one year after a minimally invasive replacement procedure. Researchers…
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Thousands enrolled in supraflex stent registry for coronary artery disease
Disease control Recruiting nowThis registry is tracking 10,000 patients with coronary artery disease who receive the Supraflex sirolimus-eluting stent during routine care. The goal is to see how well the stent works in everyday practice, measuring outcomes like heart-related death, heart attacks, and the need…
Sponsor: Sahajanand Medical Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC